This document is a Tripartite Memorandum of Understanding (MoU) between the Department of Biotechnology (DBT), the Indian Council of Medical Research (ICMR), and the International AIDS Vaccine Initiative (IAVI). It outlines the history of collaborative research projects between these parties, including HIV vaccine development, clinical trials, and bilateral collaborations. The MoU serves to formalize the ongoing partnership to address global health challenges such as HIV/AIDS, Tuberculosis, and COVID-19. It highlights successful initiatives like the HIV Vaccine Translational Research Laboratory and the National Clinical Research Program (CoHRPICA). The agreement aims to foster scientific cooperation to develop improved biomedical tools and public health solutions.

This document is a Tripartite Memorandum of Understanding (MoU) between the Department of Biotechnology (DBT), the Indian Council of Medical Research (ICMR), and the International AIDS Vaccine Initiative (IAVI). It outlines the history of collaborative research projects between these parties, including HIV vaccine development, clinical trials, and bilateral collaborations. The MoU serves to formalize the ongoing partnership to address global health challenges such as HIV/AIDS, Tuberculosis, and COVID-19. It highlights successful initiatives like the HIV Vaccine Translational Research Laboratory and the National Clinical Research Program (CoHRPICA). The agreement aims to foster scientific cooperation to develop improved biomedical tools and public health solutions.